Our news
Â鶹Íø's CEO Presents at Morgan Stanley 23rd Annual Global Healthcare Conference | September 2025
Â鶹Íø's CEO - Michael Shih - recently presented the Â鶹Íø story at the Morgan Stanley Global Healthcare Conference on Monday September 8th …
Â鶹Íø appoints Michael Shih as Chief Executive Officer
Â鶹Íø appoints Michael Shih as Chief Executive Officer Highly experienced corporate development leader with a track record of international pharma …
Â鶹Íø closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb
Â鶹Íø closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb Additional funding will be used to explore …
Â鶹Íø presented preclinical data from our PMS2 program at the AACR Annual Meeting, San Diego, 5 - 10 April 2024.
The Â鶹Íø team attended the American Association for Cancer Research Annual Meeting in San Diego, 5 - 10 April 2024. In collaboration with The …
Other news
CEO Jeff Roix spoke to BioCentury about how Â鶹Íø Ltd is developing small molecules to inhibit DNA mismatch repair (MMR) and create a pool of …
APM Health: Interview with CEO, Jeff Roix
Scrip Emerging company profile: UK-based Â鶹Íø, founded in 2017, is developing novel cancer therapies based on DNA-repair technology. The company …